ISTERIAN

Welcome to the Brand page for “ISTERIAN”, which is offered here for Drug discovery services; pharmaceutical drug development services; pharmaceutical product evaluation; pharmaceutical products development; pharmaceutical research and development; research and development in the field of inhibiting and reducing the pathological accumulation of extracellular matrix (ecm) proteins; research and development in the field of fibrosis; scientific research for medical purposes in the field of fibrosis; scientific research for medical purposes in the field of inhibiting and reducing the pathological accumulation of extracellular matrix (ecm) proteins;.

Its status is currently believed to be active. Its class is unavailable. “ISTERIAN” is believed to be currently owned by “Cambrian BioPharma, Inc.”


Owner:
CAMBRIAN BIOPHARMA, INC.
Owner Details
Description:
Drug discovery services; Pharmaceutical drug development services; Pharmaceutical product evaluation; Pharmaceutical products development; Pharmaceutical research and development; Research and development in the field of inhibiting and reducing the pathological accumulation of extracellular matrix (ECM) proteins; Research and development in the field of fibrosis; Scientific research for medical purposes in the field of fibrosis; Scientific research for medical purposes in the field of inhibiting and reducing the pathological accumulation of extracellular matrix (ECM) proteins;
Categories: DRUG DISCOVERY SERVICES